Latest Investor Engagement News

Compumedics reported a record $60.3 million in FY26 revenue, driven by an 18% year-on-year increase and a 70% jump in SaaS recurring revenues from Somfit and Nexus 360. The company resolved supply chain disruptions and targets faster EBITDA growth in FY27.

Barkly Rare Earths (ASX:BAK) is launching a substantial 10,000-metre drilling campaign targeting expansion of its 40 million tonne inferred rare earth resource at the Barkly Project, with drilling set to start imminently.

EMC Gold appoints Agne Ahlenius as CEO, reinforcing its strategic pivot to Spain with leadership focused on advancing the Salave Gold Project’s permitting and stakeholder engagement.

Boss Energy has delivered on its revised FY26 uranium production guidance with 1.41 million pounds of U3O8 and accelerated its feasibility study for the Honeymoon project, aiming to unlock future growth with a new life-of-mine plan by August 2026.

Australis Oil and Gas has submitted a permit application for the first well under its US$46.25 million carried work program in the Tuscaloosa Marine Shale, targeting a Q4 2026 spud and expanding its held-by-production acreage.

BOA Resources has appointed geologist Graeme Purcell as Managing Director following its acquisition of the Thaduna and Green Dragon copper deposits, setting the stage for a drilling campaign at Neds Creek.

BlackRock Investment Management (Australia) has announced estimated cash distributions for 16 Australian iShares ETFs, with payments scheduled for mid-July 2026. Investors must be registered by 2 July and ensure bank details and tax certifications are up to date.

Prairie Lithium restructures its board to sharpen focus on commercial lithium production, with Paul Lloyd stepping up as Executive Chairman to lead corporate strategy and financing.

Judo Bank has raised its FY26 cost of risk guidance due to three specific customer exposures, yet maintains a strong profit outlook with a projected 30% increase in pre-tax earnings.

Paradigm Biopharmaceuticals has completed enrolment ahead of schedule in its pivotal Phase 3 trial for Zilosul®, enrolling 538 patients with knee osteoarthritis and maintaining its timeline for interim and final results.

Felix Gold has created Frontier Antimony Refinery Corp., a US-focused refining platform with secured access to military-grade antimony ore from its Treasure Creek Project in Alaska, aiming to address critical supply gaps.

Axel REE has appointed Dr Patience Mpofu as Managing Director, positioning the company to advance its rare earths portfolio from exploration into commercial development with planned in-situ recovery trials.